All Insights
Exploring the science, practice, and business of medicine.
Search and Filter Insights
Showing 10 out of 12 Insights
-
Active Filters
-
How Do We Match the Right Drug to the Right Patient?
HealthSpark, Episode 20: Tanya M. Laidlaw, MD, Professor of Medicine at Harvard Medical School and allergist-immunologist at Brigham and Women’s Hospital, shows how treating severe asthma with advanced biologics can still feel like trial-and-error, and why linking patient experience, biomarkers, and research is critical to getting treatment right the first time.
-
Precision Medicine: From Population Averages to Individual Insight
As data, omics, and AI converge, precision medicine is enabling clinicians to predict disease earlier and deliver truly individualized, preventive, and more effective care.
-
How Three Harvard Medical School Experts See AI Reshaping Health Care Delivery
AI is reshaping medicine by enhancing care, safety, and education. Experts stress thoughtful use, equity, and human judgment to ensure technology augments, not replaces, clinicians.
-
Unlocking Learner Voices: How AI Can Help You Understand Qualitative Feedback
As AI continues to evolve, we may see a shift in how organizations across industries derive insights from unstructured data, adding a powerful tool in decision-making processes.
-
Health Care Insights for Corporate Learners: A Year in Review
Health care continued to evolve in transformational ways during 2023. As we look ahead, we reflect on the topics explored through our Corporate Learning Insights in 2023.
-
Medical Illustrators Bring Complex Concepts to Life
When teaching complex biomedical concepts, a strong course curriculum is important, but the visual aspects of the course are just as important to help learners understand the material more deeply.
-
Accelerating Transformation and Value Creation in Biopharmaceuticals: A Case Study with Boehringer Ingelheim
We sat down with Guido Scholze, the global head of UME at Boehringer Ingelheim, to discuss the programs’ successes and how they fit into Boehringer Ingelheim’s strategic goals.
-
Academic-Industry Collaborations Matter: Personal Perspectives of a Cancer-Surviving Physician Educator
Being diagnosed with and then recovering from lymphoma changed my life for the better. I’ve witnessed remarkable academic and industry collaboration, including the cooperation that saved my life.
-
What’s Next for the Biopharmaceutical Industry and Why Ongoing Learning is Key
The COVID-19 pandemic has led to three key trends in the biopharmaceutical industry: new therapeutic modalities, increased data usage, and stronger collaboration between industry and academia.
-
The Impact of Online Courses on Knowledge and Confidence: Insights for Corporate Learning
Online courses provide a convenient and flexible option, but can they truly deliver significant knowledge gains? Researchers from Harvard Medical School conducted a study to answer this question.
